APA (7th ed.) Citation

You, R., Yang, Y., Yin, G., Jiang, H., Lu, Y., Gui, L., . . . Feng, L. (2023). CPEB2 Suppresses Hepatocellular Carcinoma Epithelial–Mesenchymal Transition and Metastasis through Regulating the HIF-1α/miR-210-3p/CPEB2 Axis. Pharmaceutics, 15(7), 1887. https://doi.org/10.3390/pharmaceutics15071887

Chicago Style (17th ed.) Citation

You, Ran, Yanjun Yang, Guowen Yin, Hao Jiang, Yousheng Lu, Liang Gui, Jun Bao, Qingyu Xu, and Liang Feng. "CPEB2 Suppresses Hepatocellular Carcinoma Epithelial–Mesenchymal Transition and Metastasis Through Regulating the HIF-1α/miR-210-3p/CPEB2 Axis." Pharmaceutics 15, no. 7 (2023): 1887. https://doi.org/10.3390/pharmaceutics15071887.

MLA (9th ed.) Citation

You, Ran, et al. "CPEB2 Suppresses Hepatocellular Carcinoma Epithelial–Mesenchymal Transition and Metastasis Through Regulating the HIF-1α/miR-210-3p/CPEB2 Axis." Pharmaceutics, vol. 15, no. 7, 2023, p. 1887, https://doi.org/10.3390/pharmaceutics15071887.